Teva Pharmaceuticals Adopts Veeva Vault CRM for Global Commercial Operations
Event summary
- Teva Pharmaceuticals has committed to Veeva Vault CRM globally as of May 27, 2026.
- Veeva Vault CRM is part of the Vault CRM Suite, designed for commercial execution in life sciences.
- The platform includes the Agentic Call Report to generate Commercial Evidence using compliant free text.
- Teva serves as one of Veeva's over 1,500 customers, ranging from large pharmaceutical companies to emerging biotechs.
The big picture
Teva's adoption of Veeva Vault CRM underscores the growing reliance on specialized CRM solutions in the life sciences sector. This move aligns with broader industry trends toward digital transformation and data-driven commercial strategies. Veeva's ability to serve over 1,500 customers highlights its scale and market penetration, positioning it as a key player in the pharmaceutical technology space.
What we're watching
- Customer Retention
- Whether Veeva can sustain Teva's long-term commitment amid evolving commercial needs.
- Market Expansion
- The pace at which Veeva can onboard additional large pharmaceutical clients.
- Product Differentiation
- How Veeva's AI-driven CRM features will impact competitive positioning.
Related topics